Filter Results
:
(68)
Show Results For
-
All HBS Web
(68)
- News (30)
- Research (19)
- Multimedia (1)
- Faculty Publications (8)
Show Results For
-
All HBS Web
(68)
- News (30)
- Research (19)
- Multimedia (1)
- Faculty Publications (8)
- Web
Named Fellowship Funds - Alumni
J. Doris (MBA 1977/JD 1978). Shortly after her birth on March 31, 1992, Clare was diagnosed with biliary atresia, a rare pediatric liver disease, and after two liver transplants, she died at 16 months. Clare's parents wished to make a...
View Details
- 01 Dec 2023
- News
Wide Horizon
There were three critical events that led John Rodakis (MBA 1997) to form the nonprofit N of One in 2014 and ultimately dedicate his life to surfacing breakthrough autism research. The first occurred on Thanksgiving of 2012. He had driven about four hours with his wife...
View Details
Keywords:
Dan Morrell; Photos by Sarah Wilson
- Web
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows - MBA
Blog Blog MBA Voices Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Career and Professional Development Staff Author HBS Community Author HBS Faculty Author MBA Admissions Author MBA Students Topics Topics 1st Year (RC) 2+2 Program 2nd Year...
View Details
- Web
2023 Reunion Presentations - Alumni
could/should have done differently to protect longstanding ESG values at the company. Participants left the session with a better understanding of the corporate law and business issues raised in complex corporate deals. Slides Ending Alzheimer’s View Details
- 01 Jun 2023
- News
From Big Pharma to Startup
the life cycle of the company”—from proof of concept to platform and product development. It plans to focus first on creating oral versions of peptide hormone drugs used to treat rare endocrine and metabolic diseases. Although Goble is no...
View Details
Keywords:
April White
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children with rare diseases more accessible and...
View Details
- Web
Student Research - Doctoral
Kesselheim and Benjamin N. Rome Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease. Objective: To...
View Details
- Web
Publications - Institute For Strategy And Competitiveness
Mayumi Kharabi, and Robert S. Kaplan In this study the authors sought to apply a value (outcomes and cost) analysis to extracorporeal life support (ECLS), a relatively rare but very expensive ICU therapy with highly variable outcomes....
View Details
- Web
Building Collections | Baker Library | Bloomberg Center | Harvard Business School
Termeer’s leadership of Genzyme and his role as an advocate and mentor within the global biotechnology industry. Henri Termeer and Senator Ted Kennedy, undated. Henri Termeer papers. In the 1990s, Termeer championed the orphan drug movement, promoting the needs of...
View Details
- Web
Doubling Down on Women’s Health Innovation and Leveraging the Private Sector in a Post-Roe v. Wade Era - Blog: Health Supplement
products. You Might Want to Read 24 May 2023 Student Spotlight: 2023 HCC Co-Presidents Reflect on Their Time at HBS and the Current Health Care Systems Morgan Moncada & Hannah Truong 28 Feb 2023 Rare Disease...
View Details
- Profile
Emily Schlichting
At age 19, in the spring of 2009, Emily Schlichting was diagnosed with Behcet's, a rare autoimmune disease that introduced her "to the realities of U.S. health care firsthand." Although the View Details
- 31 Jan 2014
- News
Body, Heal Thyself
messenger RNA (mRNA) Therapeutics. The data that Bancel saw that evening were shocking. The numbers suggested Moderna had found an entirely new way to treat diseases—one that promised to change the medical world, resulting in cures for View Details
- 30 Jul 2007
- Research & Ideas
Repugnant Markets and How They Get That Way
was get some of the gains from exchange without exciting the repugnance that forbids markets. One could imagine that a law about kidney sales might come about if the courts decided that it was unreasonable for someone who was dying of kidney View Details
Keywords:
by Martha Lagace
- 22 Aug 2022
- Research & Ideas
Can Amazon Remake Health Care?
we desperately need more meaningful innovation for a whole host of diseases—diabetes, cardiovascular disease, Parkinson’s, Alzheimer’s, and ALS. We want cures, not chronic disease management. How does Amazon’s foray into health care help...
View Details
- 17 Dec 2007
- Research & Ideas
The Rise of Medical Tourism
What used to be rare is now commonplace: traveling abroad to receive medical treatment, and to a developing country at that. So-called medical tourism is on the rise for everything from cardiac care to plastic surgery to hip and knee...
View Details
- 15 Dec 2003
- Research & Ideas
The New Global Business Manager
Massachusetts. Their Cerezyme plant runs twenty-four hours a day, 365 days a year, and produces six kilos of product in all that time. You could fit it in a little six-pack bag. But it is sufficient to treat the 6,000 people around the world—and that's all there...
View Details
Keywords:
by Cynthia Churchwell
- 25 Aug 2022
- News
Up on the Corner
It’s a drab gray morning in April, and real estate developer Nadine Ngouabe Dlodlo (MBA 2008) is standing at the corner of West Baltimore and South Calhoun Streets in Baltimore’s historic Union Square district. Behind her, a chain-link fence decorated with a small...
View Details
- 25 Apr 2014
- News
A revolution in healing
formerly was CEO of bioMérieux. He joined the company in 2011 after seeing impressive data indicating Moderna had found an entirely new way to treat rare diseases and cancer—using technology that was...
View Details
- Web
Financial Aid - HBS Fund Investors Society 2021 Report
Financial Aid Financial Aid From Scholarships to Life-Saving Impact Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children with View Details
- 01 Dec 2013
- News
Your Own Medicine
conference room at DART's Cambridge office. After several years in consulting and a few years launching start-ups, Williams spent eight years at Genzyme, managing its rare disease portfolio, leaving in 2006...
View Details